Clover Biopharmaceuticals’ SCB-2019 COVID-19 Vaccine Shows Strong Immune Response in Third Shot Study
China-based Clover Biopharmaceuticals Ltd (HKG: 2197) has published clinical data for its COVID-19 vaccine candidate...
NMPA
NHSA Releases Draft Proposals for NRDL Annual Renewal Process
The National Healthcare Security Administration (NHSA) has formulated and released draft proposals for rules covering...
Enhancing Clinical Trial Success: CDE’s New Adaptive Design Framework Opens for Comment
The newly proposed guidelines are designed to be applicable across a spectrum of confirmatory clinical...